ClinicalTrials.gg
RecruitingNCT06049355Updated Oct 13, 2026

EMBRACE: Exercising Together

A Phase 2 interventional study of Exercise Intervention and Biospecimen Collection in Breast Carcinoma and Prostate Carcinoma, sponsored by OHSU Knight Cancer Institute. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-13.

Sponsored by OHSU Knight Cancer Institute · Phase 2, Interventional, and Supportive care

How we know

From the registry’s dates

  • Started Apr 2024; still recruiting 2 years 7 months later.
Updated Oct 13, 2026Eligibility revisedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 2
Study type
Interventional
Enrollment
400
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 29 studies in Breast Neoplasms by OHSU Knight Cancer Institute — 3 open to participants now, 4 under way, none of them phase 3. Breast Neoplasms · OHSU Knight Cancer Institute.

Planned enrollment
2nd of 24
400 · median 37
Started
2024
with 1 other
Phase 2
5 of 29
2 open now
Registered
29th of 29
by date

Among the 29 studies in Breast Neoplasms by OHSU Knight Cancer Institute, this one is the 2nd largest by planned enrollment of the 24 interventional ones that give a count, is one of 2 that started in 2024, is one of 5 in phase 2, and was the 29th registered.

Breast Neoplasms

14,855 studies on the registry are indexed under Breast Neoplasms; 3,321 are open to participants now.

Browse Breast Neoplasms studies →

Open to participants now

3 of the 29 studies in Breast Neoplasms by OHSU Knight Cancer Institute are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 2,403 Breast Neoplasms studies recruiting now, 1,574 (66%) set no upper age limit and 591 (25%) stop at 75 or younger; 103 take children under 18; 215 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 29 studies in Breast Neoplasms by OHSU Knight Cancer Institute, or all of them as a file.
02

Study summary

This phase II trial tests how well an exercise intervention, Exercising Together, works in preventing declines in physical and mental health in couples during radiation treatment for cancer. Treatments for cancer can cause side effects such as fatigue as well as strain on relationships. Exercising Together is a partnered exercise program that adds communication, collaboration and support between partners during exercise to fortify the relationship and amplify the benefits of physical training. Exercising Together program may be effective on the mental and physical health of couples during radiation treatment for cancer.

Read the detailed description

PRIMARY OBJECTIVE:

I. To test the effectiveness and mechanisms of the adapted Exercise Together intervention on mental and physical health of couples (Aims 1 \& 2).

SECONDARY OBJECTIVE:

I. To gain better understanding of the implementation context and implementation outcomes (Aim 3).

ADMINISTRATIVE SUPPLEMENT AIMS:

I. To develop and apply novel computational models that analyze the joint effects of three or more temporally co-occurring modifiable risk factors on cancer outcomes.

II. Adequate access to temporal data at the individual level for each risk factor by using 24-hour actigraphy data collected on cancer dyads participating in the parent trial.

III. Applying a structural equation modeling approach to examine congruence of co-occurring movement behaviors within and between cancer dyads participating in behavioral intervention trial to improve dyadic cancer outcomes.

OUTLINE: Patients are randomized to 1 of 2 arms.

ARM I: Patients and partners undergo Exercising Together exercise program during radiation therapy on study. Patients also undergo collection of blood samples throughout the trial.

ARM II: Patients and partners receive educational materials specific to exercise. Patients also undergo collection of blood samples throughout the trial.

03

Conditions studied

  • Breast Carcinoma
  • Prostate Carcinoma
04

Who can participate

The criteria were revised on the registry on Oct 13, 2026. See what changed

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • INTERVENTION (SURVIVORS) INCLUSION

    • confirmed prostate cancer or breast cancer without evidence of disease
    • Confirmed by review of the electronic medical record (EMR) and subsequently recorded in Survivor Health History. In cases where the EMR isn't clear, their Oregon Health \& Science University (OHSU) provider will be contacted for confirmation. For non-OHSU patients, we'll initially collect their cancer health history by a self-report questionnaire and confirm when we receive the survivor's outside medical record (through a signed Release of Information)
  • Scheduled to receive radiation therapy for curative intent

    • Confirmed by review of the EMR and subsequently recorded in Survivor Health History. In cases where the EMR isn't clear, their OHSU provider will be contacted for confirmation/ For non-OHSU patients, we'll initially collect their cancer health history by a self-report questionnaire and confirm when we receive the survivor's outside medical record (through a signed Release of Information)

      • Completed surgery >= 6 weeks prior to enrollment and no concurrent therapy other than ADT for prostate cancer or hormone therapy for breast cancer
    • Confirmed by self-report on the Health History Questionnaire (HHQ). If unknown, the participant's healthcare provider will be contacted for confirmation
  • Co-residing with an intimate partner or spouse who is willing to participate

    • Confirmed by self-report on the Demographic Questionnaire
  • INTERVENTION (SURVIVORS AND PARTNERS) INCLUSION
  • 18 years of age and older

    • For survivors: confirmed by review of the date of birth as documented in the Electronic Medical Record (EMR) and subsequently recorded in Survivor Health History. For non-OHSU patients, we'll collect their age by self-report on the Survivor Health History
    • For partners: confirmed by self-report on the Health History Questionnaire
  • \< 2 structured strength training sessions for less than 30 minutes per week in the last month

    • Confirmed by self-report on Health History Questionnaire
  • Home internet sufficient for videoconferencing

    • Confirmed by staff review of Internet Connectivity Screening Guide with the participants and outcome recorded in a CRF
  • Signed

    • Confirmed by completion of e-Consent in REDCap
  • Willing to be randomized into either study arm and adhere to study protocol

    • Confirmed verbally with the participant and response documented in the Participant Tracking database
  • IMPLEMENTATION INCLUSION
  • Be one of these key stakeholders: patient, spouse/partner, healthcare providers, or administrator
  • Verbal informed consent following receipt of an Information Sheet

Exclusion criteria

Exclusion Criteria:

  • INTERVENTION (SURVIVORS AND PARTNERS) EXCLUSION
  • Cognitive difficulties that preclude answering the survey questions, participating in the exercise classes or performance tests, or providing

    • In the event of a suspected undeclared cognitive impairment, it will be confirmed by physician clearance or professional opinion of the Principal Investigator, Kerri Winters-Stone
  • A medical condition, movement or neurological disorder, or medication use that contraindicates participation in moderate intensity exercise. Specific include the following: poorly controlled diabetes, recent cardiac event, neuromuscular disease, untreated orthostatic hypertension, recent surgery, acute hernia, acute rheumatoid arthritis, severe memory disorders, severe balance disorder, inability to ambulate without a walker or wheelchair, inability to stand for 3 minutes, severe hearing or vision problem

    • Confirmed by a combination of reviewing the EMR, self-report on the Health History Questionnaire, Charlson Comorbidity Index questionnaire, and/or by physician clearance. If in the professional opinion of the Principal Investigator, Dr. Kerri Winters-Stone, contraindications other than those identified by the patient or physician are present, she may consider the participant ineligible. For Spouse/Partner: must answer 'No'; to American College of Sports Medicine pre-participation screening questions. If spouse/partner answers 'Yes'; to either question they may be required to obtain physician clearance prior to becoming eligible. Physician clearance may also be requested at the discretion of the principal investigator.

      • Not fluent in English and therefore incapable of answer survey questions, following directions during exercise or performance testing, and providing informed consent in English
    • Confirmed by staff interaction and/or the professional opinion of the Principal Investigators, Dr. Kerri Winters-Stone
Terms in these criteria, in plain language(5)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Histologically or cytologically confirmed

The diagnosis was confirmed by looking at a sample under a microscope: tissue from a biopsy or surgery (histology), or cells from a fluid or needle sample (cytology).

Your pathology report is the document that shows this.

Metastases

Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.

Adjuvant and neoadjuvant

Neoadjuvant treatment is given before the main treatment (usually surgery), often to shrink a tumor. Adjuvant treatment is given after it, to lower the chance of the cancer coming back.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Phase 2
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
400 participants (estimated)

Study arms

  • Experimental
    Arm I (Exercise Together exercise program)

    Patients and partners undergo Exercising Together supervised group exercise program using live remote video conference technology over 75 minutes three times a week (TIW) for 8 weeks during radiation therapy on study. Patients also undergo collection of blood samples using self-collection methods throughout the trial.

    Other: Exercise Intervention · Procedure: Biospecimen Collection

  • Active comparator
    Arm II (educational material)

    Patients and partners receive educational materials specific to exercise. Patients also undergo collection of blood samples using self collection methods throughout the trial.

    Procedure: Biospecimen Collection · Other: Educational Intervention

Interventions

  • OtherExercise Intervention

    Undergo Exercise Together exercise program, a supervised group exercise program delivered online, using a live remote format

  • ProcedureBiospecimen Collection

    Undergo collection of blood samples

    Also known as: Biological Sample Collection, Biological Sample Collection, Biospecimen Collected, Biospecimen Collection, Specimen Collection

  • OtherEducational Intervention

    Receive educational materials

    Also known as: Education for Intervention, Intervention by Education, Intervention through Education, Intervention, Educational

06

What researchers measure

Primary outcomes

  1. Physical functioning

    Measured by the Physical Performance Battery (PPB) to determine a person's ability to perform daily tasks independently. The PPB consists of 3 timed tests: 5 repeated chair stands, standing balance, and usual pace gait speed over 4 meters. Each test is scored 0 (unable) to 4 (completes without difficulty), based on quartiles of performance, then scores are summed. The possible range of scores is 0-12.

    Time frame: Baseline, Months 2, Month 4, and Month 6

  2. Anxiety

    Measured by the Patient Reported Outcomes Measurement Information System (PROMIS) anxiety short form using questions on a scale ranging from 1 (never) to 5 (always).

    Time frame: Baseline, Month 1, Month 2, Month 4, and Month 6

Secondary outcomes

  1. Changes in patient-reported symptoms: fatigue

    Measured by PROMIS FACIT-Fatigue to assess how tired, weak, or limited a person feels due to fatigue. Will use the 13-item measure for symptoms in the past 7 days using questions on a scale ranging from 1 (not at all) to 5 (very much).

    Time frame: Baseline, Month 1, Month 2, Month 4, and Month 6

  2. Changes in patient-reported symptoms: mental health

    Measured by PROMIS to assess symptoms of mental health such as sadness, worthlessness, and hopelessness. Will use the 8-item measures for symptoms in the past 7 days using questions on a scale ranging from 1 (never) to 5 (always).

    Time frame: Baseline, Month 1, Month 2, Month 4, and Month 6]

  3. Changes in patient-reported symptoms: global health

    Measured by PROMIS to assess symptoms of global health (QoL). Global health is assessed with a 10-item measure that asks about physical, mental and social functioning using questions on a scale ranging from 1 (poor/not at all/always/sever) to 5 (excellent/completely/never/none) and a 0 (no pain) to 10 (worst imaginable pain) scale.

    Time frame: Baseline, Month 1, Month 2, Month 4, and Month 6

  4. Sexual function and satisfaction

    Assessed with a 14-item measure in the past 30 days and is specific to either male or female

    Time frame: Baseline, Month 1, Month 2, Month 4, and Month 6

  5. Sleep Behavior: total sleep time

    Measured using ActiGraph Link, we will have extended wear time to measures total sleep time over a 3-day monitoring period.

    Time frame: Baseline, Months 2, Month 4, and Month 6

  6. Inflammation - high sensitivity C-Reactive Protein (hsCRP)

    Measured using a self-administered dried blood spot (DBS) collection kit. Participants are taught by research staff and follow a YouTube video to use a finger stick poke to obtain a drop of blood that is put onto a sample card. DBS captured on the designated card are dried thoroughly (\> 4 hours at room temperature), then inserted into a foil pouch with desiccant and mailed to the research team. Cards are frozen (0 degree Fahrenheit \[F\] or below) until analyzed.

    Time frame: Baseline, Months 2, and Month 6

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — All individual quantitative participant data collected during the trial, after deidentification.

Time frame: Beginning 3 months following final publication.

Access criteria: Access will be provided to investigators who provide a methodologically sound proposal and complete a data sharing agreement that includes commitments to: (1) using the data only for research purposes and not to identify any individual participant, (2) securing the data using appropriate computer technology, and (3) destroying or returning the data after analyses are completed. Proposals should be directed to wintersk@ohsu.edu. To gain access to data, data requestors will need to sign a data sharing agreement.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2024 (actual). Primary completion is estimated for Jun 2028, 50 months after the start.

Of 1,070 non-industry phase 2 interventional studies under Breast Neoplasms, half reached primary completion within 56 months of starting (the median), counting those still running; a quarter within 34 and three quarters within 89. This study's planned 50 months is below that.

Counting every sponsor, half of 1,302 studies reached it within 51 months; a quarter within 30 and three quarters within 83.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 11, 2023
First posted
Sep 22, 2023
StartActual
Apr 18, 2024
Primary completionEst.
Jun 30, 2028
CompletionEst.
Sep 1, 2028
Last update
Oct 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Eligibility
1 inclusion criterion edited, 2 added; 1 exclusion criterion edited, 2 added
What changed in the criteria
Inclusion criteria
  • AddedCompleted surgery >= 6 weeks prior to enrollment and no concurrent adjuvant therapy other than ADT for prostate cancer or hormone therapy for breast cancer
  • AddedConfirmed by self-report on the Health History Questionnaire (HHQ). If unknown, the participant's healthcare provider will be contacted for confirmation
  • Edited\&lt;< 2 structured strength training sessions for less than 30 minutes per week in the last month
Exclusion criteria
  • EditedConfirmed by a combination of reviewing the EMR, self-report on the Health History Questionnaire, Charlson Comorbidity Index questionnaire, and/or by physician clearance. If in the professional opinion of the Principal Investigator, Dr. Kerri Winters-Stone, contraindications other than those identified by the patient or physician are present, she may consider the participant ineligible. For Spouse/Partner: must answer \&#39;'No\&#39'; to American College of Sports Medicine pre-participation screening questions. If spouse/partner answers \&#39;'Yes\&#39'; to either question they may be required to obtain physician clearance prior to becoming eligible. Physician clearance may also be requested at the discretion of the principal investigator.
  • AddedNot fluent in English and therefore incapable of answer survey questions, following directions during exercise or performance testing, and providing informed consent in English
  • AddedConfirmed by staff interaction and/or the professional opinion of the Principal Investigators, Dr. Kerri Winters-Stone
Oct 13, 2026
Secondary outcomes
1 edited, 2 added
What changed in the outcomes
  • EditedChanges in patient-reported symptoms: fatigueTime frame: Baseline, Month 1, Month 2, Month 4, and Month 6
  • AddedChanges in patient-reported symptoms: mental healthTime frame: Baseline, Month 1, Month 2, Month 4, and Month 6]
  • AddedChanges in patient-reported symptoms: global healthTime frame: Baseline, Month 1, Month 2, Month 4, and Month 6
Oct 13, 2026
Show all 1 update
  1. Oct 13, 2026
    Eligibility 1 inclusion criterion edited, 2 added; 1 exclusion criterion edited, 2 added
    What changed in the criteria
    Inclusion criteria
    • AddedCompleted surgery >= 6 weeks prior to enrollment and no concurrent adjuvant therapy other than ADT for prostate cancer or hormone therapy for breast cancer
    • AddedConfirmed by self-report on the Health History Questionnaire (HHQ). If unknown, the participant's healthcare provider will be contacted for confirmation
    • Edited\&lt;< 2 structured strength training sessions for less than 30 minutes per week in the last month
    Exclusion criteria
    • EditedConfirmed by a combination of reviewing the EMR, self-report on the Health History Questionnaire, Charlson Comorbidity Index questionnaire, and/or by physician clearance. If in the professional opinion of the Principal Investigator, Dr. Kerri Winters-Stone, contraindications other than those identified by the patient or physician are present, she may consider the participant ineligible. For Spouse/Partner: must answer \&#39;'No\&#39'; to American College of Sports Medicine pre-participation screening questions. If spouse/partner answers \&#39;'Yes\&#39'; to either question they may be required to obtain physician clearance prior to becoming eligible. Physician clearance may also be requested at the discretion of the principal investigator.
    • AddedNot fluent in English and therefore incapable of answer survey questions, following directions during exercise or performance testing, and providing informed consent in English
    • AddedConfirmed by staff interaction and/or the professional opinion of the Principal Investigators, Dr. Kerri Winters-Stone
    Secondary outcomes 1 edited, 2 added
    What changed in the outcomes
    • EditedChanges in patient-reported symptoms: fatigueTime frame: Baseline, Month 1, Month 2, Month 4, and Month 6
    • AddedChanges in patient-reported symptoms: mental healthTime frame: Baseline, Month 1, Month 2, Month 4, and Month 6]
    • AddedChanges in patient-reported symptoms: global healthTime frame: Baseline, Month 1, Month 2, Month 4, and Month 6
    + 4 other changes: verification date, oversight details, description and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06049355
Responsible party
Kerri Winters (Principal Investigator, OHSU Knight Cancer Institute) — Principal investigator
First posted
Sep 22, 2023
Start date
Apr 18, 2024
Primary completion
Jun 30, 2028 (estimated)
Completion
Sep 1, 2028 (estimated)
Last update
Oct 13, 2026

Study contacts

Carolyn Guidarelli
Contact
exercise@ohsu.edu
503-494-0444
Kerri Winters-Stone
principal investigator · OHSU Knight Cancer Institute

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion